Santarus, S2 Therapeutics Inc., VeroScience sales and marketing update

Santarus launched Cycloset bromocriptine in the U.S. to treat Type II diabetes. VeroScience and S2 granted Santarus exclusive rights in the U.S. to commercialize the timed-release tablet in September...